Skip to main content
. Author manuscript; available in PMC: 2013 Apr 8.
Published in final edited form as: Cell Cycle. 2009 Jul 23;8(14):2266–2280. doi: 10.4161/cc.8.14.9101

Figure 1.

Figure 1

Analyses of VEGFR-3 expression in human breast cancer specimens. Human breast samples staining with VEGFR-3 9D9F9 antibody. Left panel normal tissue, center hyperplasia ADH measured as 2+, right—DCIS staining measured as 2+. Diaminobenzidine (DAB) was used as the chromogen, and the slides were counter-stained with hematoxylin.